Staff Reporter (Health Care, Law)
Amgen Inc. on Thursday announced that the U.S. Food and Drug Administration has accepted the biologics license application for Aimovig, a drug for prevention of migraine.
FloQast Inc. on Tuesday announced the appointment of Rob Feinstein as vice president of product.
Amgen Inc. on Tuesday announced a collaboration agreement with Array BioPharma for development of drugs for autoimmune disorders.
MannKind Corp. on Monday announced that Steven Binder has joined the company as chief financial officer.
Amgen Inc.’s leukemia drug Blincyto has received full approval from the U.S. Food and Drug Administration, the company has announced.
MannKind Corp. on Wednesday announced that Patrick McCauley will join the company as chief commercial officer.
Cure Pharmaceuticals on Tuesday announced that it has signed a memorandum to enter into a research collaboration with two Israeli companies.
Simulation Plus Inc. on Monday reported fiscal third-quarter earnings that showed rising revenue and net income.
EDUCATION: Seventh-graders take first step to health jobs.
Feeling it’s never too early to start preparing for a career, Palmdale Prepatory Academy debuts focusing seventh graders on health care.
ACQUISITION: Verizon latest suitor linked to Burbank media conglomerate.
Rumors of takeover boosts Disney’s stock price.